Primary Rat and Mouse Hepatic Stellate Cells Express the Macrophage Inhibitor Cytokine Interleukin–10 During the Course of Activation In Vitro
Open Access
- 30 December 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 28 (6) , 1518-1524
- https://doi.org/10.1002/hep.510280611
Abstract
Activation of local tissue macrophages (Kupffer cells) and of quiescent hepatic stellate cells (HSCs) to a myofibroblast phenotype are two key events in liver inflammation and fibrosis. It is known that products of activated macrophages may activate stellate cells. We have hypothesized that the products of activated HSCs may also modulate the activity of Kupffer cells. The cytokine interleukin–10 (IL–10), produced by lymphocytes and macrophages, has profound inhibitory actions on macrophages. Normal rat and mouse HSCs that differentiate in vivo and in vitro to activated myofibroblasts were isolated by enzyme perfusion and density centrifugation with or without centrifugal elutriation, confirmed by vitamin A autofluorescence and positive immunostaining for the myofibroblast markers desmin and smooth muscle actin (SMA). Conditioned media and lysates from these cells were found to down–regulate lipopolysaccharide (LPS)–induced tumor necrosis factor–α (TNF–α) secretion by the mouse macrophage line RAW 267.4. In highly purified preparations of rat HSCs, messenger RNA (mRNA) for IL–10 was detected by reverse–transcription polymerase chain reaction (RT–PCR), from the time of isolation to up to 120 days of culture on plastic. Long–term cultures of unstimulated mouse HSCs secreted IL–10 protein as detected by immunoblotting and specific enzyme–linked immunosorbent assay (ELISA). IL–10 protein was undetectable by immunohistochemistry in mouse HSCs for the first 3 days in culture. After this, the percentage of IL–10-positive cells increased to 45% at day 7 and 100% by day 14, and expression of IL–10 continued in long–term cultures of up to 120 days. The expression of IL–10 by the stromal cells that govern the fibrotic process in the liver may have important implications for the regulation of inflammation and fibrosis in the liver.Keywords
This publication has 33 references indexed in Scilit:
- Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta.The Journal of Experimental Medicine, 1995
- Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challengeJournal of Hepatology, 1995
- Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophagesJournal of Hepatology, 1994
- Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.Journal of Clinical Investigation, 1994
- Kupffer Cells: Their Activation and Role in Animal Models of Liver Injury and Human Liver DiseaseSeminars in Liver Disease, 1993
- Biological properties of interleukin 10Immunology Today, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type β1 and type αBiochemical and Biophysical Research Communications, 1990
- Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.Journal of Clinical Investigation, 1989